Bitcoin halving
What does that mean?
$2.78T
Total marketcap
$140.07B
Total volume
BTC 49.80%     ETH 15.44%
Dominance

Viking Therapeutics VKTX Stock

83.34 USD {{ price }} 3.105276% {{change_pct}}%
Exchange
NasdaqCM
Market Cap
8.99B USD
LOW - HIGH [24H]
78.65 - 85.18 USD
VOLUME [24H]
6.66M USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.91 USD

Viking Therapeutics Price Chart

Viking Therapeutics VKTX Financial and Trading Overview

Viking Therapeutics stock price 83.34 USD
Previous Close 22.39 USD
Open 22.18 USD
Bid 0 USD x 800
Ask 0 USD x 800
Day's Range 21.96 - 22.78 USD
52 Week Range 2.11 - 25.72 USD
Volume 1.44M USD
Avg. Volume 4.93M USD
Market Cap 2.24B USD
Beta (5Y Monthly) 0.667605
PE Ratio (TTM) N/A
EPS (TTM) -0.91 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 33.8 USD

VKTX Valuation Measures

Enterprise Value 2.1B USD
Trailing P/E N/A
Forward P/E -23.395832
PEG Ratio (5 yr expected) -0.73
Price/Sales (ttm) N/A
Price/Book (mrq) 13.28994
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Viking Therapeutics Stock Price History

Beta (5Y Monthly) 0.667605
52-Week Change 898.22%
S&P500 52-Week Change 20.43%
52 Week High 25.72 USD
52 Week Low 2.11 USD
50-Day Moving Average 21.55 USD
200-Day Moving Average 10.52 USD

VKTX Share Statistics

Avg. Volume (3 month) 4.93M USD
Avg. Daily Volume (10-Days) 1.89M USD
Shares Outstanding 99.84M
Float 93.9M
Short Ratio 3.68
% Held by Insiders 6.24%
% Held by Institutions 46.86%
Shares Short 11.89M
Short % of Float 13.74%
Short % of Shares Outstanding 11.91%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -26.97%
Return on Equity (ttm) -45.70%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA N/A
Net Income Avi to Common (ttm) -72295000 USD
Diluted EPS (ttm) -0.89
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 135.66M USD
Total Cash Per Share (mrq) 1.36 USD
Total Debt (mrq) 1.49M USD
Total Debt/Equity (mrq) 1.11 USD
Current Ratio (mrq) 9.551
Book Value Per Share (mrq) 1.69

Cash Flow Statement

Operating Cash Flow (ttm) -62510000 USD
Levered Free Cash Flow (ttm) -37637248 USD

Profile of Viking Therapeutics

Country United States
State CA
City San Diego
Address 9920 Pacific Heights Boulevard
ZIP 92121
Phone 858 704 4660
Website https://www.vikingtherapeutics.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 22

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; VK2735, a novel dual agonist of the glucagon-like peptide, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.

Q&A For Viking Therapeutics Stock

What is a current VKTX stock price?

Viking Therapeutics VKTX stock price today per share is 83.34 USD.

How to purchase Viking Therapeutics stock?

You can buy VKTX shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Viking Therapeutics?

The stock symbol or ticker of Viking Therapeutics is VKTX.

Which industry does the Viking Therapeutics company belong to?

The Viking Therapeutics industry is Biotechnology.

How many shares does Viking Therapeutics have in circulation?

The max supply of Viking Therapeutics shares is 107.93M.

What is Viking Therapeutics Price to Earnings Ratio (PE Ratio)?

Viking Therapeutics PE Ratio is now.

What was Viking Therapeutics earnings per share over the trailing 12 months (TTM)?

Viking Therapeutics EPS is -0.91 USD over the trailing 12 months.

Which sector does the Viking Therapeutics company belong to?

The Viking Therapeutics sector is Healthcare.

Viking Therapeutics VKTX included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16399.52 USD
+0.51
4.29B USD 16279.17 USD 16431.82 USD 4.29B USD
NASDAQ Capital Market Composite RCMP 122.55 USD
+1.18
120.53 USD 122.55 USD
NASDAQ HealthCare IXHC 1012.23 USD
+1.45
999.52 USD 1012.31 USD
NASDAQ Composite Total Return I XCMP 19928.44 USD
+0.52
19782.2 USD 19967.69 USD